Ticlopidine-induced severe agranulocytosis after the placement of coronary artery stent - A case report
Küçük Resim Yok
Tarih
2000
Yazarlar
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Westminster Publ Inc
Erişim Hakkı
info:eu-repo/semantics/closedAccess
Özet
Ticlopidine is an oral antiplatelet agent frequently utilized in the treatment of cerebrovascular disease. It is rarely associated with severe bone marrow suppression. A case of an elderly woman is reported who developed febrile agranulocytosis two months after commencing ticlopidine but who had a favorable outcome after cessation of that drug and treatment with granulocyte colony-stimulating factor (G-CSF). All patients should have regular monitoring of their blood counts during therapy with ticlopidine.
Açıklama
Anahtar Kelimeler
Severe Aplastic-Anemia, Mechanism, Therapy
Kaynak
Angiology
WoS Q Değeri
Q4
Scopus Q Değeri
Q2
Cilt
51
Sayı
7
